MeSH tree: C04.557.337.539.275
Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer's disguise: a protein called CD43 on ...
Apr 10, 2026
0
7
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia Laboratory have developed a data-sharing platform that unites genomics, gene expression and clinical information ...
Apr 6, 2026
0
3
Some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood. A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid ...
Apr 6, 2026
0
5
A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) have found a way to switch it back on. In a study published in Science Translational Medicine, the team reveals ...
Apr 2, 2026
0
8
Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often more effective than single agents, their true mechanisms of action have been poorly understood. A ...
Mar 30, 2026
0
3
After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia School of Medicine assistant professors Tomasz Cierpicki and Jolanta Grembecka are working to restore ...
Mar 19, 2026
0
5
Patients undergoing intensive chemotherapy for acute myeloid leukemia are routinely treated with multiple antibiotics to prevent infection, a practice that new research from Texas A&M University shows can significantly reshape ...
Mar 9, 2026
0
7
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be contained by chemotherapy (remission), ...
Mar 5, 2026
0
10
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an assistant research professor in bioengineering at Northeastern University, says that AML also has a high ...
Mar 4, 2026
0
6
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone marrow and blood. This ...
Feb 26, 2026
0
13
